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ABSTRACT Previous work has shown that environmental and clinical isolates of Aspergillus fumigatus represent a diverse popu-
lation that occupies a variety of niches, has extensive genetic diversity, and exhibits virulence heterogeneity in a number of ani-
mal models of invasive pulmonary aspergillosis (IPA). However, mechanisms explaining differences in virulence among A. fu-
migatus isolates remain enigmatic. Here, we report a significant difference in virulence of two common lab strains, CEA10 and
AF293, in the murine triamcinolone immunosuppression model of IPA, in which we previously identified severe low oxygen mi-
croenvironments surrounding fungal lesions. Therefore, we hypothesize that the ability to thrive within these lesions of low oxy-
gen promotes virulence of A. fumigatus in this model. To test this hypothesis, we performed in vitro fitness and in vivo virulence
analyses in the triamcinolone murine model of IPA with 14 environmental and clinical isolates of A. fumigatus. Among these
isolates, we observed a strong correlation between fitness in low oxygen in vitro and virulence. In further support of our hypoth-
esis, experimental evolution of AF293, a strain that exhibits reduced fitness in low oxygen and reduced virulence in the triamcin-
olone model of IPA, results in a strain (EVOL20) that has increased hypoxia fitness and a corresponding increase in virulence.
Thus, the ability to thrive in low oxygen correlates with virulence of A. fumigatus isolates in the context of steroid-mediated mu-
rine immunosuppression.
IMPORTANCE Aspergillus fumigatus occupies multiple environmental niches, likely contributing to the genotypic and pheno-
typic heterogeneity among isolates. Despite reports of virulence heterogeneity, pathogenesis studies often utilize a single strain
for the identification and characterization of virulence and immunity factors. Here, we describe significant variation between
A. fumigatus isolates in hypoxia fitness and virulence, highlighting the advantage of including multiple strains in future studies.
We also illustrate that hypoxia fitness correlates strongly with increased virulence exclusively in the nonleukopenic murine tri-
amcinolone immunosuppression model of IPA. Through an experimental evolution experiment, we observe that chronic hyp-
oxia exposure results in increased virulence of A. fumigatus. We describe here the first observation of a model-specific virulence
phenotype correlative with in vitro fitness in hypoxia and pave the way for identification of hypoxia-mediated mechanisms of
virulence in the fungal pathogen A. fumigatus.
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Among both eukaryotic and prokaryotic pathogens, includingthe pathogenic fungus Aspergillus fumigatus, genomic analy-
ses have revealed a startling level of genetic diversity within single
species (1–6). An emerging theme in fungal pathogenesis is the
extension of this characterization to intraspecies phenotypic het-
erogeneity. Of particular interest is variation in virulence across
clinical and environmental isolates, extending to laboratory
strains referenced as “wild-type” (“WT”) strains in pathogenesis
studies (7–11). For A. fumigatus, studies of phenotypic and viru-
lence heterogeneity have been reported. These include reports of
variation in growth in vitro (12, 13) and virulence in multiple
animal models of aspergillosis, including a Drosophila melano-
gaster model (12), murine models (14), and Galleria mellonella
larval models (15, 16). Comparisons between two commonly used
“WT” laboratory strains, CEA10 and AF293, have begun to reveal
differences in the immune response elicited by each strain (17).
While this research has started to highlight phenotypic heteroge-
neity across strains, causal connections between strain genetics, in
vitro phenotypes, and virulence have yet to be identified. Because
virulence is a multifaceted characteristic, both the complex envi-
ronment of the host and specific factors of the pathogen should be
considered to identify mechanisms of pathogenesis and virulence
for each host-pathogen interaction (18). Although an ideal anti-
fungal therapeutic would kill the fungus in any host context with-
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out extensive collateral damage, mechanistic insights into host
context-specific virulence mechanisms are expected to yield novel
therapeutic approaches in specific patient populations. To realize
this opportunity, the genotypic and phenotypic heterogeneities of
both the pathogen and host need to be understood. Consequently,
exploring intraspecies genotypic and phenotypic heterogeneity in
the A. fumigatus populations presents an exciting opportunity to
better understand the virulence of this important human patho-
gen and uncover novel therapeutic strategies in specific patient
populations.
The microenvironment of the lung in immunocompromised
hosts has been postulated to select for certain A. fumigatus geno-
types and phenotypes, allowing the fungus to thrive in vivo, and
has been alluded to in competitive index studies and in the devel-
opment of drug resistance in clinical strains (19–22). However,
the specific selective pressures of various ex vivo environments
that enable environmental isolates to better respond to the host
and increase virulence remain enigmatic (5, 19, 23). Several as-
pects of the host microenvironment that represent potential selec-
tive pressures have been characterized. These include alternations
in pH (24, 25), oxygen tensions (26, 27), and nutrient availability
(28, 29), among others. While great strides are being made toward
understanding how A. fumigatus responds to such stresses, utiliz-
ing multiple strains to elucidate mechanisms could significantly
enhance these efforts.
While assessing the mechanism of virulence across multiple
strains in vivo, it should be considered that the host microenviron-
ment varies between susceptible populations of patients depend-
ing on the state and mechanism of immune suppression. This
creates an even more complex interplay of host-pathogen interac-
tions and complicates the understanding of A. fumigatus re-
sponses to the host (30). While the majority of invasive pulmo-
nary aspergillosis (IPA) cases have been reported among
neutropenic individuals, it has recently been recognized that the
number of nonneutropenic patients diagnosed with IPA is in-
creasing (31, 32). This shift in IPA patient populations highlights
the relevance of the murine triamcinolone model of infection,
which presents a different in vivo microenvironment than the leu-
kopenic (neutropenic) model (26, 30). For example, we have
described variability in tissue oxygen levels between these mod-
els, where pulmonary lesions in both models reach oxygen ten-
sions below 1%; however, low oxygen (or hypoxic) lesions in
triamcinolone-treated mice, with increased host cell infiltrates,
encompass larger areas of tissue than those in leukopenic mice
(26).
The ability of A. fumigatus to adapt to low oxygen (or hypoxia)
is essential for virulence, as the master transcriptional regulator of
the hypoxia response in A. fumigatus, SrbA, is essential for growth
in hypoxia (5% O2) in vitro and for virulence in both the triam-
cinolone and leukopenic murine models of IPA (33, 34). Consid-
ering the hypoxic nature of the infected lung, these data suggest
that the ability to adapt to low-oxygen environments is critical for
growth within the host and virulence. Therefore, we tested the
hypothesis that among a heterogeneous group of strains those
more fit in low-oxygen environments are more virulent.
Here, we report a strong correlation between in vitro hypoxic
growth phenotypes and A. fumigatus virulence. We observe that
the commonly utilized laboratory strains AF293 and CEA10 have
markedly different growth phenotypes in liquid culture under
normal-oxygen (normoxic) and low-oxygen (hypoxic) condi-
tions. Strikingly, these two strains have a significant difference in
virulence in a triamcinolone murine model of IPA despite similar
virulence levels within a leukopenic (neutropenic) model. There-
fore, we expanded our characterization of A. fumigatus strains
using a selection of environmental and clinical isolates to test
whether the ability to thrive under low oxygen conditions impacts
pathogenesis and virulence in the triamcinolone model of IPA.
Our characterization of these strains showed heterogeneity across
isolates in several in vitro growth phenotypes and a correlation
between higher hypoxia fitness and increased virulence in this
model. In further support of these observations, virulence of a
strain with low hypoxia fitness increases with experimental evolu-
tion through in vitro low-oxygen conditions, supporting a hy-
pothesis that hypoxia fitness is a major factor in A. fumigatus vir-
ulence in specific host contexts.
RESULTS
Two common laboratory strains display virulence heterogene-
ity in a triamcinolone immunosuppression murine model and
varied fitness phenotypes in vitro. Heterogeneity between two
commonly used laboratory strains, AF293 and CEA10, has been
noted previously by our lab for qualitative hypoxia fitness in vitro
(35), but the importance of this observation has not been thor-
oughly explored. Given our previous data highlighting the role of
hypoxia fitness in A. fumigatus virulence, we sought to quantita-
tively measure in vitro fitness under various oxygen environments
for the two “WT” strains. To examine this, we measured radial
growth (Fig. 1A) and liquid biomass (Fig. 1B) of CEA10 and
AF293 in 1% glucose minimal medium (GMM) in normoxia (am-
bient air, ~21% O2) and hypoxia (0.2% O2). On solid medium in
hypoxia, CEA10 has significantly greater radial growth than
AF293 (P  0.0001) (Fig. 1A). In liquid culture, we found that
biomass of AF293 is significantly increased (P  0.0004) in nor-
moxia compared to CEA10 after 48 h. Conversely, CEA10 pro-
duces more biomass after 48 h in hypoxia than AF293 (Fig. 1B). To
account for the ability of each individual strain to grow in hypoxia
relative to normoxia, we calculated the ratio of biomass in hypoxia
to biomass in normoxia (H/N) for each strain and observed that
the H/N fitness ratio of CEA10 is significantly (P  0.0165) higher
than AF293 (Fig. 1C). We conclude that CEA10 has greater hyp-
oxia fitness than AF293.
As we have previously observed extensive low oxygen regions
within pulmonary fungal lesions in the murine triamcinolone model
of IPA compared to the leukopenic model (26), we hypothesized that
the increased in vitro hypoxia fitness of CEA10 would allow for in-
creased virulence in the murine triamcinolone model of IPA. In a
controlled side-by-side comparison, CEA10 is significantly (P 
0.0002) more virulent than AF293 in this model of IPA as quantified
by murine mortality (Fig. 1D). However, consistent with previous
studies from several laboratories, in the chemotherapeutic model
(33), the two strains display nearly identical virulence levels (P 
0.2426) as measured by murine mortality, where 90 to 100% of mice
succumb to infection by 12 days postinoculation (Fig. 1E). To evalu-
ate the pathology of disease for each strain, we prepared lungs for
histological analysis from both models 3 days postinoculation (dpi).
Gomori methenamine silver (GMS) staining reveals greater fungal
load and denser fungal growth with CEA10 than with AF293 in the
triamcinolone and chemotherapeutic models of IPA (Fig. 1F and G).
It is also evident that CEA10 demonstrates increased lung paren-
chyma invasion, whereas AF293 is more often retained in larger air-
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ways. Staining with hematoxylin and eosin (H&E) illustrates in-
creased inflammation for both strains in the triamcinolone model
compared to the chemotherapeutic model (Fig. 1F and G). Taken
together, these data highlight differences in in vivo fungal fitness and
the inflammatory response between these two laboratory “WT”
strains. Based on the observation that the significant increase in the
H/N growth ratio of CEA10 corresponds to its increased virulence in
the triamcinolone model of IPA, we hypothesized that H/N fitness
ratio could be used as a predictor of virulence across A. fumigatus
strains in the context of steroid-mediated immune suppression.
In vitro hypoxia fitness heterogeneity exists among clinical
and environmental isolates. To test our hypothesis that increased
hypoxia fitness might predict the virulence of A. fumigatus strains
in an immunosuppression-dependent context, we expanded our
analysis to a random selection of A. fumigatus environmental and
clinical isolates confirmed through morphological analysis and
sequencing of the calmodulin gene and internal transcribed spacer
(ITS) region (data not shown). Four clinical isolates were col-
lected through lung biopsies (M35662 and F78107) and bronchial
washes (F30186 and W73763), and 10 environmental isolates
were selected from broad geographic regions, including air sam-
ples (47-57, 47-60, and 47-9), an indoor hospital sample (47-4),
sawmill samples (47-10 and 47-7), and three samples from Neth-
erlands (02-46, 02-10, and 02-30) (Table 1). The 10th environmen-
tal isolate is from a sputum sample (W72310) and is included among
the environmental isolates, as events of single isolation from sputum
FIG 1 Two common lab strains, CEA10 and AF293, show phenotypic variation and strikingly different virulence in a triamcinolone model of IPA but not a
leukopenic model of IPA. (A) Radial growth of CEA10 and AF293 on GMM in normoxia (~21% O2) and hypoxia (0.2% O2) at 96 h. (B) Biomass from liquid
cultures grown in 1% glucose minimal medium (GMM) in normoxia and hypoxia at 48 h. ***, P  0.0004; n.s., not significant by unpaired, two-tailed t test. (C)
Ratio of biomass in hypoxia to biomass in normoxia, as calculated with values from panel B. *, P  0.0165 by unpaired, two-tailed t test. (D) Survival analysis of
CEA10 (n  20 from 2 independent experiments) and AF293 (n  27 from 3 independent experiments) in a triamcinolone model of IPA in CD-1 mice inoculated
with 2  106 conidia intranasally. **, P  0.0002 by log rank test. (E) Survival analysis of CEA10 (n  16) and AF293 (n  17) in a chemotherapeutic model of
IPA in CD-1 mice inoculated with 2  106 conidia intranasally. n.s., not significant by log rank test. (F and G) Hematoxylin and eosin (H&E) or Gomori
methenamine silver (GMS) stains of lungs 3 days postinoculation from triamcinolone-treated mice (F) and chemotherapy-treated leukopenic mice (G)
inoculated with 2  106 AF293 or CEA10 conidia. Images are representative of three mice, and all error bars indicate standard errors of the means.
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are often categorized as environmental contaminants during the col-
lection process (36, 37). As observed with the two “WT” strains, there
is a range of fitness phenotypes among the clinical and environmental
isolates on solid medium and liquid biomass cultures in both nor-
moxia and hypoxia (Fig. 2A, B, and C). Interestingly, the environ-
mental isolates, in general, show greater variation in biomass under
both conditions than the clinical isolates (Fig. 2C). Taken together,
these data illustrate that significant hypoxia fitness heterogeneity ex-
ists across A. fumigatus strains.
To determine if strain heterogeneity extends to differences in
virulence, we assessed virulence of the respective environmental
and clinical isolates in the triamcinolone murine model of IPA.
Similarly to the in vitro phenotypic heterogeneity, the environ-
mental isolates produce a spectrum of virulence, with median sur-
vival ranging from 12.5 (W72310) to 5.5 (47-4) dpi (Fig. 3A and
B). Among the clinical isolates, the median survival ranges from 5
(M35662) to 10 (F78107) dpi (Fig. 3C). Given that the difference
in virulence between CEA10 and AF293 is specific to the triamcin-
olone model, we assessed virulence of an isolate with hypoviru-
lence in the triamcinolone model, 02-10, and an isolate with
hypervirulence in the triamcinolone model, 47-4, in the chemother-
apeutic model. Similarly to the “WT” strains, we did not observe a
significant difference in virulence between the two isolates in this
leukopenic model (P  0.1851 [Fig. 3D]). Taken together, these data
illustrate heterogeneity across A. fumigatus isolates in in vitro growth
phenotypes and virulence in a host-specific manner. We hypothe-
sized that like the “WT” strains, the hypoxia fitness of these isolates
correlates with the virulence in the triamcinolone model of IPA.
A higher ratio of hypoxic to normoxic fitness correlates with
increased virulence in triamcinolone-treated mice. To test
whether there is a correlation between hypoxia fitness and viru-
lence in the triamcinolone model of IPA, we determined the H/N
ratio of each isolate (Fig. 4A). Among the environmental isolates,
the H/N ratio varied from higher, CEA10-like ratios (47-4 and
47-10) to lower AF293-like ratios (W72310 and 02-10). The clin-
ical isolates showed modest variation but interestingly were more
similar to each other than the environmental isolates and fell in
the middle range of the H/N ratios for CEA10 and AF293
(Fig. 4A). Spearman’s rank order correlation analysis, for non-
parametric data (38), of the H/N fitness ratio versus the median
murine survival for each strain revealed a significant correlation
(Spearman’s rho, r  0.7867, P  0.0003) between the two
metrics (Fig. 4B), supporting the hypothesis that increased fitness
in hypoxia yields higher virulence in the triamcinolone model of
IPA. If we separate isolates into distinct environmental and clini-
cal groups and test the correlation of each group, both remain
significant, with a Spearman’s rho (r) of 0.7031 (P  0.0268) for
the environmental isolates (Fig. 4C) and a Spearman’s rho (r) of
0.9429 (P  0.0167 [Fig. 4D]) for the clinical isolates. As con-
trols for nonnormalized growth, we included the Spearman cor-
relation between hypoxic-only and normoxic-only biomass and
median survival. The correlations with hypoxia biomass (r 
0.6788; P  0.0038 [Fig. 4E]) and normoxia biomass (r 
0.5199; P  0.0390 [Fig. 4F]) are both significant but are less
robust than the H/N correlation. However, it is important to note
that the correlation of normoxic biomass and median survival is
positive, indicating that increased growth capacity under normal
lab conditions negatively correlates with virulence in this cohort
of strains and murine model. Notably, this correlation is host spe-
cific, as there is no correlation between median survival in the
chemotherapeutic model and the H/N ratio (r  0.2582; P 
0.75) with 02-10, 47-4, CEA10, and AF293 (data not shown).
Taken together, these data support a hypothesis that fitness in
hypoxia, not overall growth in normoxia, correlates with higher
virulence of A. fumigatus in the triamcinolone model of IPA and
that this correlation is host specific.
Interestingly, the environmental isolate 47-10 appears to be an
outlier within this correlation, displaying an increased median
survival compared to that predicted by the hypoxia fitness ratio.
Although correlations reveal connections between two pheno-
TABLE 1 Geographic origins of A. fumigatus isolates used in this study
Strain Origin Source
Lab “wild-type” strains
AF293 Lung biopsy specimen of neutropenic IPA patient David Denning Laboratory
CEA10 (CBS144.89) Patient with IPA CBS-KNAW Fungal Biodiversity Centre
Environmental isolates
47-4 (AF250, FA210) Salford Hope Hospital, Manchester, UK Paul Dyer, Nottingham, UK
47-10 (AF221) Sawmill wood, New Zealand Paul Dyer, Nottingham, UK
47–57 (AFIR957) Air sample, Dublin, Ireland Paul Dyer, Nottingham, UK
W72310 Sputum Memorial Sloan Kettering, NY, USA
47-7 (AF217) Sawmill, Sweden Paul Dyer, Nottingham, UK
47-9 (AF70) Air sample, NJ, USA Paul Dyer, Nottingham, UK
47-60 (AFRB3) Air samples, Dublin, Ireland Paul Dyer, Nottingham, UK
08-19-02-10 (02-10) Netherlands, Nijmegen Darius Armstrong, Imperial College London, London, UKa
08-19-02-30 (02-30) Netherlands, Berghem Darius Armstrong, Imperial College London, London, UKa
8-19-02-46 (02-46) Netherlands, Nijmegen Darius Armstrong, Imperial College London, London, UKa
Clinical isolates
M35662 Lung biopsy specimenb Memorial Sloan Kettering, NY, USA
F78107 Lung biopsy specimenb Memorial Sloan Kettering, NY, USA
F30186 Bronchial wash Memorial Sloan Kettering, NY, USA
W73763 Bronchial wash Memorial Sloan Kettering, NY, USA
a See reference 75 for information on this Netherlands strain.
b These are proven invasive aspergillosis based on modified EORTC criteria.
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types, they do not necessarily portray causal relationships. As vir-
ulence is a multifaceted characteristic, the outlier 47-10 may uti-
lize alternative mechanisms that account for the high hypoxia
fitness without displaying the expected increase in virulence in the
triamcinolone model of IPA. Such strains, although outliers
within the correlation, can be informative in the identification of
traits influencing A. fumigatus virulence. One potential mecha-
nism known to influence virulence and host immune responses is
cell wall polysaccharide microbe-associated molecular patterns
(MAMPs). Moreover, hypoxia is known to dramatically alter the
cell wall of A. fumigatus and Candida albicans (39, 40). However,
cell wall integrity analysis of these strains on the cell wall-
perturbing agents Congo red (CR) and calcofluor white (CFW) in
normoxia and hypoxia does not reveal any obvious phenotypes
correlative to virulence (see Fig. S1 in the supplemental material).
For example, 47-10 displayed increased resistance to Congo red
and CFW in normoxia and hypoxia, similarly to hypoxia-fit and
virulent strains 47-4 and CEA10. Ongoing work is focused on
uncovering the possible mechanisms of hypoxia-mediated viru-
lence observed in the strains analyzed.
In vitro experimental evolution of a strain with low fitness in
hypoxia leads to increased virulence. With the observed correla-
tion between virulence and fitness in hypoxia, we sought to exper-
imentally test the hypothesis that increased fitness in hypoxia pro-
motes virulence. Consequently, experimental evolution was
performed by serially passaging the laboratory “WT” strain
AF293, which exhibits low fitness in hypoxia (Fig. 1B) and atten-
uated virulence in the triamcinolone model of IPA (Fig. 1D). Fol-
lowing 20 passages in hypoxia, the resulting A. fumigatus strain,
named EVOL20, exhibits increased fitness in hypoxia as deter-
mined by colony diameter (P  0.0026 [Fig. 5A]) and liquid bio-
mass (P  0.0448 [Fig. 5B]) compared to the parental strain. In-
terestingly, in normoxia, EVOL20 also displays increased colony
density and radial growth on solid medium at 96 h (Fig. 5A) but
displays significantly reduced biomass in normoxic liquid cultures
compared to AF293 (P  0.0001 [Fig. 5B]). This increased fitness
results in a significantly (P  0.0111) increased hypoxia fitness
ratio (H/N) of EVOL20 compared to AF293 (Fig. 5C). To deter-
mine whether this ratio correlates with increased virulence of the
strain, we used a low-dose (1  105 conidia) triamcinolone model
of IPA and observed that EVOL20 has a remarkably significant
increase in virulence over AF293 (P  0.0296 [Fig. 5D]). Histol-
ogy results from 3 dpi postinoculation reveal greater invasion of
EVOL20 into the lung parenchyma and a general increase in fun-
gal growth and inflammation compared to lungs inoculated with
AF293 (Fig. 5E). Notably, the EVOL20 strain also displays in-
creased virulence compared to AF293 in the chemotherapeutic
model of IPA (P  0.0003); however, the median survival differs
only from day 4 for AF293 to day 3 for EVOL20 (Fig. 1E and 3D).
While the underlying mechanisms are an ongoing area of study,
these data suggest that increased hypoxia fitness promotes viru-
lence in A. fumigatus.
FIG 2 Clinical and environmental isolates show heterogeneity in hypoxic
growth. (A) Radial growth of clinical and environmental isolates on GMM
under normoxia and hypoxia conditions. (B and C) Four clinical isolates,
M35662, F78107, F30186, and W73763 (n  4) (B), and the remaining envi-
ronmental isolates (n  10) (C) reveal heterogeneity in biomass from liquid
culture in normoxia (~21% O2) and hypoxia (0.2% O2). Data are presented as
the means from biological triplicates with error bars representing standard
errors of the means.
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DISCUSSION
The use of a single strain for the study of pathogenesis and
virulence is a common practice in the field of molecular patho-
genesis and immunity; however, the increased appreciation for
dramatic intraspecies heterogeneity suggests the need to in-
clude multiple strains in such studies of virulence. Besides the
known clinical implications of pathogen heterogeneity, intras-
pecies variation provides an outstanding opportunity to better
define the virulence mechanisms of a given microbial species.
A. fumigatus strains, including WT reference strains, clinical
isolates, and environmental isolates, have previously been
shown to have significant genetic diversity and to display phe-
notypic heterogeneity in vitro and in vivo (3, 12–17, 41). Cur-
rently, two studies have proposed correlations between A. fu-
migatus isolates, describing a relationship between normoxic
fungal growth rate and virulence in the murine neutropenic
model of IPA (n  9) (42) and between gliotoxin production
and virulence in the G. mellonella model of IPA (n  4) (43).
However, such studies utilize a relatively low number of exclu-
sively clinical A. fumigatus isolates and do not extend the anal-
yses to the diverse group of environmental isolates or virulence
in multiple host contexts. Therefore, further analysis of such
mechanisms of virulence in a diverse group of isolates may
highlight strain-specific virulence factors and host-adaptation
strategies, as well as strain-specific host responses, such as
those observed between the two “WT” reference strains of
A. fumigatus, CEA10 and AF293 (44, 45). Heterogeneity in vir-
ulence has been observed for several other pathogenic fungi,
including Cryptococcus neoformans (46), Paracoccidioides
brasiliensis (47, 48), C. albicans (49), and Histoplasma capsulatum
(50); however, for most fungi, the possible contributing mecha-
nisms have yet to be fully defined. Laboratory passaging of C. neo-
formans serotype A strain H99 results in genomic alterations yield-
ing several phenotypically diverse lineages, several of which are
avirulent (46). Similarly, P. brasiliensis isolates are also reported to
display virulence heterogeneity, and individual isolates lose viru-
lence as a result of in vitro laboratory passaging (47), partially as a
result of reduced -1,3-glucan content of the cell wall (48). More-
over, virulence and in vivo phenotypic heterogeneities have also
been observed in subsets of C. albicans strains characterized by
white or opaque colonies (49). These observations of phenotypic
and virulence heterogeneity in medically important fungi high-
light the broad implications of recognizing diversity within a spe-
cies and underscore the opportunity to define novel mechanisms
of virulence in multiple strains of A. fumigatus.
Here, we report significant heterogeneity in A. fumigatus viru-
lence between two widely used laboratory “WT” strains, AF293
and CEA10, in the triamcinolone murine model of IPA. This sig-
nificant difference in virulence between the two strains is depen-
dent on the host immune status, as the strains display nearly iden-
tical virulence levels in a murine chemotherapeutic model of IPA,
where the host is largely leukopenic. This is not the first instance of
reported variation between these two strains, as Rizzetto and col-
leagues (17) reported a number of differences between them in an
immunocompetent murine model, which included differences
in the inflammatory response and increased pulmonary fungal
burden and mortality in CEA10-challenged mice compared to
AF293-challenged mice. Analysis of the cytokine profiles induced
FIG 3 Clinical and environmental isolates present a spectrum of virulence in the triamcinolone model of IPA but not in a chemotherapeutic model. (A and B)
Data are separated into two distinct graphs for easy viewing. Triamcinolone-treated CD-1 mice inoculated with 2  106 conidia of 02-10 (n  12), 47-9 (n  11),
02-30 (n  12), 47-10 (n  16), 47-4 (n  16), 47-60 (n  12), 47-7 (n  12), 02-46 (n  13), W72310 (n  16), or 47-57 (n  16) reveal a range of virulence
levels across the isolates. (C) Clinical isolates (n  16 per strain) inoculated in triamcinolone-treated CD-1 mice at 2  106 conidia reveal reduced heterogeneity
in virulence (curves not significantly different by log rank test; P  0.2296). (D) Survival of mice treated with both cyclophosphamide and triamcinolone
(chemotherapeutic model) were inoculated with 2  106 conidia of 47-4, 02-10, or EVOL20 (n  12 per strain). In this model, all three strains produce curves
that are indistinguishable from one another (log rank, P  0.1851 for 47-4 and 02-10).
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by each strain revealed that CEA10 elicits a more potent
interleukin-17 (IL-17) response by dendritic cells in vitro and in
the immunocompetent murine model, while AF293 drives a
higher production of IL-10, IL-1, and gamma interferon
(IFN-), further suggesting that the immune response during an
infection is strain dependent (17).
Comparisons of these strains at the genome level reveal that
although 98% of each genome can be aligned with high identity
FIG 4 Higher ratio of hypoxia-to-normoxia biomass correlates with increased virulence in the triamcinolone model of IPA. (A) Ratio of liquid culture biomass
in hypoxia (0.2% O2) to normoxia (~21% O2) for environmental and clinical isolates. (B to D) Spearman rank order correlations calculated from H/N ratio and
median survival (n  16; r  0.7867; P  0.0003) for all strains (B) (clinical isolates [diamonds], lab-utilized “WT” strains [squares], and environmental
isolates [circles]) and separated by environmental (n  10; r  0.7031; P  0.0268) (C) and clinical (n  6; r  0.9429; P  0.0390) (D) isolates. (E and F)
Spearman rank order correlations and median survival for all 16 strains of hypoxia-only biomass (r  0.6788; P  0.0038) (E) and normoxia-only biomass (r 
0.5199; P  0.0390) (F).
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(99.3 to 99.8%), 1.4% and 2.3% of AF293 and CEA10, respec-
tively, harbor unique genes. Furthermore, 41 orthologous gene
pairs between the two strains do not share 100% identity, and
alignment of some of these genes shows identities as low as 37%
(51). Taken together, the influence of the variable host environ-
ment and the genetic heterogeneity of A. fumigatus strains pres-
ents multiple opportunities to better understand causative mech-
anisms underlying virulence in the increasingly common
nonneutropenic patient population.
Building upon the known heterogeneity in these “WT” strains,
our study demonstrates that AF293 and CEA10 have significantly
different fitness levels in low-oxygen (hypoxic) environments
FIG 5 Serial passaging of a strain with low hypoxia fitness increases growth and virulence in triamcinolone-treated mice. (A and B) Radial growth (A) and liquid
biomass (B) on GMM in normoxia (~21% O2) and hypoxia (0.2% O2). ***, P  0.0001; *, P  0.0448, by unpaired, two-tailed t test. (C) Ratio of hypoxia biomass
to normoxia biomass for EVOL20 compared to the parental AF293 strain. *, P  0.0111 by unpaired, two-tailed t test. (D) Survival analysis with a low-dose
inoculum (1  105 conidia) in the triamcinolone-treated CD-1 mice (*, P  0.0296 by log rank test; n  10 per strain). (E) Hematoxylin and eosin (H&E) or
Gomori methenamine silver (GMS) stains of lungs 3 days postinoculation from triamcinolone-treated CD-1 mice inoculated with 1  105 conidia. Images are
representative of 3 mice.
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when normalized to their fitness in normal-oxygen (normoxic)
environments. This ratio of hypoxia fitness correlates with the
significant variation in virulence between these two strains.
CEA10 not only is more virulent in the triamcinolone murine
model of IPA but also displays significantly increased hypoxia
fitness as measured by total biomass and colony diameter. This
observation led us to hypothesize that increased hypoxia fitness
drives increased virulence in host contexts characterized by exten-
sive hypoxia at the site of infection. Hypoxia is a known charac-
teristic of host microenvironments for infections caused by patho-
genic organisms, including Mycobacterium tuberculosis and
Histoplasma capsulatum (52–55). Hypoxic lesions have been ob-
served in several tuberculosis animal models, including rats,
guinea pigs, rabbits, and nonhuman primates (53, 55), and have
been suggested to serve as a trigger for M. tuberculosis bacterios-
tasis, a critical stage of dormancy in M. tuberculosis pathology (56).
Moreover, H. capsulatum causes lesions in the murine liver that
contain regions of hypoxic tissue and is able to grow in vitro at
oxygen tensions below 1% (52). We have previously shown hyp-
oxia to also be a component of the murine pulmonary microen-
vironment during IPA with both the triamcinolone and chemo-
therapeutic models of immune suppression. Lesions in both
models reach tensions likely well below 1% O2; however, the
triamcinolone-treated mice present with larger and more severe
hypoxic lesions than those in the chemotherapeutic model (26).
In order to thrive in such an oxygen-limiting environment,
A. fumigatus requires the sterol regulatory element-binding pro-
tein (SREBP) transcription factor SrbA. We have previously
shown SrbA to be essential for A. fumigatus virulence and in vitro
hypoxic growth (33, 34). The requirement for an SREBP tran-
scription factor in virulence is not unique to A. fumigatus, as the
SrbA homolog, Sre1, of C. neoformans is essential for formation of
brain lesions in a murine model of cryptococcosis (27, 57). Fur-
ther, transcriptional analysis of H. capsulatum in hypoxia in vitro
revealed an upregulated profile of genes with binding sites consis-
tent with conserved SREBP motifs, suggesting an SrbA/Sre1-like
hypoxia response such as those characterized in A. fumigatus and
C. neoformans (52). Thus, we conclude that hypoxia is an impor-
tant feature of several host-pathogen interactions, and a patho-
gen’s ability to cope with this environmental stress is essential for
virulence.
Given the observed differences between commonly utilized
“WT” reference strains, we expanded our analysis to include sev-
eral environmental and clinical isolates to test the hypothesis that
increased hypoxia fitness correlates with increased virulence in the
triamcinolone model of IPA. We chose 10 environmental isolates,
collected from various geographic and ecological niches, and four
clinical isolates (Table 1). Interestingly, across these isolates,
greater variation in hypoxia fitness was observed among the 10
environmental isolates than among the four clinical isolates. This
reduced variation among the clinical isolates may be the result of
the intense oxygen-mediated selective pressures within the host.
Notably, the clinical isolates do not cluster based on isolation
strategies, i.e., bronchial wash versus lung biopsy. Comparing the
virulence levels of these clinical and environmental isolates, it be-
comes clear that virulence in the triamcinolone model, as mea-
sured by median survival, correlates strongly with A. fumigatus
normoxia-normalized hypoxic fitness (H/N) in liquid culture.
Importantly, this correlation applies only to the triamcinolone
model of IPA and is not present in the chemotherapeutic model,
indicating that hypoxia fitness is a virulence determinant specific
to the host immune status.
In support of this correlation between hypoxic fitness and vir-
ulence, experimental evolution was performed with AF293 and
resulted in a strain, EVOL20, which displays increased hypoxia
fitness and, importantly, increased virulence in the triamcinolone
model of IPA. Similar in vivo and ex vivo laboratory passaging
experiments have proved insightful in studies of other pathogenic
fungi, including Candida species and C. neoformans (58–60). The
ability of the A. fumigatus evolved strain (EVOL20) to develop
increased hypoxia fitness from in vitro exposure not only high-
lights a role for environmental influence on the heterogeneity of
A. fumigatus strains but demonstrates the strong selective pressure
of altered oxygen tensions for highly virulent strains. It is possible
that natural environmental conditions, with various oxygen ten-
sions, can generate genetic and phenotypic alterations that predis-
pose some environmental strains to thrive within the host, ac-
counting for at least a portion of the virulence heterogeneity that
we have reported. Given the vast environments from which A. fu-
migatus is isolated (water, air, soil, compost, etc.), the various
selective pressures of the environments may partially explain the
greater variation in phenotypes that we observe among the envi-
ronmental isolates compared to the clinical isolates. Work is on-
going to characterize the molecular mechanisms responsible for
the increased growth in hypoxia and increased virulence of the
hypoxia-evolved strain EVOL20.
Correlation analyses such as these illustrate a relationship be-
tween two phenotypes; however, it does not reveal the causal
mechanisms. However, hypoxia acts through several possible
mechanisms that may explain the correlation between hypoxia
fitness and virulence in the triamcinolone model of IPA. The ef-
fects of hypoxia on fungal biology are broad, including changes to
virulence-associated mechanisms such as the cell wall (39), cellu-
lar metabolism (61–63), iron homeostasis (63, 64), stress mitiga-
tion, and responses to host immune cells (39) (Fig. 6). The cell wall
directly interacts with the host, and in the triamcinolone model of
IPA, where immune cells can drive a hyperinflammatory response
to A. fumigatus that may result in host damage, this interface is an
obvious candidate to drive differences in virulence across strains.
Previous studies have shown that growth in hypoxia results in
thickening of the cell wall with increased -glucan exposure, and
cells grown in hypoxia elicit a more potent inflammatory response
from immune cells (39). While we did not observe any obvious
patterns of differential susceptibility to cell wall-perturbing agents
across our isolates under hypoxic conditions, detailed cell wall
composition analyses and MAMP exposure are needed to explore
this hypothesis further. Hypoxia also affects cellular metabolism
of A. fumigatus, increasing the transcription and translation of
glycolytic enzymes (62, 63) and the use of fermentative pathways
(65) while decreasing mitochondrial respiration (61). Evidence in
Saccharomyces cerevisiae suggests that decreased electron flux
through the electron transport chain paradoxically increases the
generation of reactive oxygen species (ROS) within the cell (66);
thus, mechanisms to deal with redox stresses under hypoxia are
required. To this end, the activity of the alternative oxidase is
increased in hypoxia, offering a potential mechanism to combat
an increase in cellular ROS under these conditions (61). Hypoxia
also affects metal ion metabolism, with increased transcription of
iron acquisition pathways (64) and increased iron and other crit-
ical metal content in cells under low-oxygen conditions (63).
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These cellular changes, as well as potential unexplored effects of
hypoxia, represent possible mechanisms that drive virulence in
strains that are well adapted to low-oxygen conditions, and each
strain may employ one or several of these mechanisms to thrive
within the host environment. Thus, further studies are warranted
to understand the causative links between hypoxia and virulence
and how these links vary between strains.
In addition to these effects of hypoxia on A. fumigatus, low
oxygen also affects the host response through modulation of host
cell function. Hypoxia has a myriad of known effects on myeloid
cell function, including the well-studied effects of the hypoxia-
inducible transcription factor HIF-1. HIF-1 coordinates the
cellular response to low-oxygen stress, such as that encountered
by neutrophils in the hypoxic microenvironment of infected tis-
sues. In particular, HIF-1 regulates neutrophil recruitment
down an oxygen gradient to regions of low-oxygen tensions
through the upstream regulation of 2-integrin-mediated diape-
desis (67). Once at the hypoxic lesion, the critical survival of neu-
trophils is also HIF-1 coordinated, as demonstrated by reduced
survival of HIF-1-deficient neutrophils following in vitro hyp-
oxia exposure (68). Hypoxia has also been shown to have HIF-1-
dependent effects on neutrophil effector function through regu-
lation of phagocytosis and bactericidal activity (69). We have also
previously shown that HIF-1 is required for host protection
against IPA, due to inefficient neutrophil recruitment at the site of
infection (70). Intriguingly, triamcinolone treatment strongly re-
duces HIF-1 nuclear levels and target gene expression in the lung
during A. fumigatus challenge (70). Together, the effects of low
oxygen on fungal and host-specific processes and the host-
pathogen interactions shape the disease progression, severity, and
outcome of a given host. Therefore, the specific host environment,
in conjunction with fungal genotype and phenotype, must be con-
sidered when assessing the host-pathogen interaction.
The correlation between the hypoxic growth and virulence of
A. fumigatus strains not only highlights the clinically relevant het-
erogeneity between A. fumigatus isolates from the environment
and the clinic but also suggests a role for the selective pressures of
the environment on the virulence of the organism, where those
environments that are oxygen poor may select for strains that are
better able to thrive in the hypoxic microenvironment of the in-
fected lung. These data also serve to illustrate that IPA pathology
may be directly influenced by the strain of A. fumigatus and that
the pathology of infection cannot be described merely in terms of
the host status and immune response as described previously (71).
Future work in A. fumigatus virulence studies should consider
strain variation in identification of virulence determinants to en-
compass a clinically relevant cohort of isolates and expand oppor-
tunities to develop novel therapeutic approaches in specific
patient-fungal interactions.
MATERIALS AND METHODS
Strains and media. Strains used in this study are listed in Table 1. All
strains were stored as conidial suspensions in 50% glycerol at 80°C.
Strains were grown on 1% glucose minimal medium (GMM) (72) at 37°C,
and conidia were collected in 0.01% Tween for in vitro assays. For animal
studies, spores were collected in 0.01% Tween and then resuspended in
sterile phosphate-buffered saline (PBS). For all solid media, 1.5% agar was
added prior to autoclaving.
Serial passaging of A. fumigatus AF293 through a low-oxygen envi-
ronment. The “WT” lab-adapted strain AF293 was grown for 4 days at
37°C in 0.2% O2 and 5% CO2 on GMM without FeSO4·7H2O to mimic
the oxygen- and nutrient-poor microenvironment of the host. The pop-
ulation of conidia was then subcultured/passaged for 20 generations for a
total of 80 days of hypoxic growth. The population of conidia was then
single spored, and a single spore was selected based on fitness in hypoxia
for further analyses. This strain, EVOL20, was maintained under the pas-
saging conditions prior to further analyses.
FIG 6 Hypoxia influences a myriad of biological processes in A. fumigatus and the host. Hypoxia has been shown to impact several key factors, many of which
have identified roles in virulence. Transcriptomics reveals increased expression of glycolytic enzymes as well as enzymes of the -aminobutyrate (GABA) shunt
(62). Hypoxia has been shown to cause thickening of the cell wall with increased exposure of -glucan (39). Ergosterol biosynthesis and iron homeostasis are also
transcriptionally influenced by hypoxia (64), and increased iron content in the fungi has been demonstrated under hypoxic conditions (63). Last, the cellular
response to reactive oxygen species and endoplasmic reticulum stress is altered in hypoxia as shown by increased alternative oxidase activity (AOX) (61) and a
hypoxic growth defect in ireA (74). UPR, unfolded protein response. Hypoxia-mediated host changes include increased neutrophil recruitment, survival, and
effector functions through activation of HIF-1.
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Growth assays. Radial growth was quantified by point inoculating 103
conidia on GMM plates at 37°C in normoxia (~21% O2, 5% CO2) and
hypoxia (0.2% O2, 5% CO2). Colony diameter was measured every 24 h
for 4 days and reported as the average from three biological replicates per
strain. Fungal biomass was quantified by measuring the dry weight of
fungal tissue from 5  107 conidia grown in 100 ml liquid GMM with
shaking at 200 rpm for 48 h in normoxia (~21% O2) and hypoxia (0.2%
O2, 5% CO2). Liquid biomass is reported as the average from three bio-
logical replicates per strain. Hypoxic conditions were maintained using an
Invivo2 400 hypoxia workstation (Ruskinn Technology Limited, Brid-
gend, United Kingdom) with a gas regulator and 94.8% N2.
Cell wall-perturbing agents. Serial dilutions of conidia were prepared
to create dilutions of 105 conidia to 102 conidia/2 l. Conidial dilutions
were plated on GMM containing 1 mg/ml Congo red (Sigma; catalog no.
C6277) or 25 g/ml calcofluor white (fluorescent brightener 28; Sigma;
catalog no. F3543). Plates were incubated in normoxia (~21% O2, 5%
CO2) or hypoxia (~0.2% O2, 5% CO2) for 48 h. Images are representative
of biological triplicates.
Survival analysis. The virulence of the A. fumigatus strains was as-
sessed in two murine models of IPA, the chemotherapeutic model and the
triamcinolone model. Mice were housed in autoclaved cages at 4 mice per
cage with HEPA-filtered air and autoclaved food and water available ad
libitum. For the chemotherapeutic murine model, outbred CD-1 female
mice (Charles River Laboratories, Raleigh, NC), 6 to 8 weeks old, were
immunosuppressed with intraperitoneal (i.p.) injections of cyclophosph-
amide (Baxter Healthcare Corporation, Deerfield, IL) at 150 mg/kg of
body weight 48 h before fungal inoculation and 72 h after fungal inocula-
tion, along with subcutaneous (s.c.) injections of 40 mg/kg Kenalog-10
(triamcinolone acetonide; Bristol-Myer Squibb, Princeton, NJ) 24 h be-
fore fungal inoculation and 6 days after fungal inoculation. For the mu-
rine triamcinolone model, outbred CD-1 female mice, 6 to 8 weeks old,
were treated with 40 mg/kg Kenalog-10 by s.c. injection 24 h prior to
fungal inoculation.
For both murine models with the “WT,” environmental, and clinical
isolates, conidial suspensions of 2  106 conidia were prepared in 40 l
sterile PBS and administered to mice intranasally while under isoflurane
anesthesia. Mock mice were given 40 l PBS without fungal spores. Mice
were monitored three times a day for signs of disease for 14 days postin-
oculation. Virulence of EVOL20 and parental AF293 inocula from pas-
saging conditions was assessed in the triamcinolone murine model, where
mice were immunosuppressed as previously described and received a low-
dose conidial suspension of 105 conidia in 40 l sterile PBS 24 h after
Kenalog-10 injection. Survival was plotted on Kaplan-Meier curves, and
statistical significance between curves was determined using the Mantel-
Cox log rank.
Histopathology. Outbred CD-1 mice, 6 to 8 weeks old, were immu-
nosuppressed and intranasally inoculated with conidia as described above
for the chemotherapeutic and corticosteroid murine models. Three mice
in each group were inoculated with either 2  106 AF293 conidia, 2  106
CEA10 conidia, 1  105 EVOL20 conidia, or 1  105 AF293 conidia from
the passaging conditions as described above. Mice were sacrificed 72 h
postinoculation. Lungs were perfused with 10% buffered formalin phos-
phate before removal and then stored in 10% buffered formalin phos-
phate until embedding. Paraffin-embedded sections were stained with
hematoxylin and eosin (H&E) and Gomori methenamine silver (GMS).
Slides were analyzed microscopically with a Zeiss Axioplan 2 imaging
microscope (Carl Zeiss Microimaging, Inc., Thornwood, NY) fitted with a
QImaging Retiga-SRV Fast 1394 RGB camera. Analysis was performed
with Phylum Live 4 imaging software.
Ethics statement. We carried out our animal studies in strict accor-
dance with the recommendations in the Guide for the Care and Use of
Laboratory Animals (73). The animal experimental protocol was approved
by the Institutional Animal Care and Use Committee (IACUC) at Dart-
mouth, College (federal-wide assurance number A3259-01).
Statistics and correlation analysis. All statistical analyses were done
with Prism 5 software (GraphPad Software Inc., San Diego, CA). Corre-
lations were calculated using the Spearman rank order correlation analysis
for nonparametric data. All error bars represent standard errors of the
means.
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